We collected information about Dicerna Pharmaceuticals Inc Hours for you. Follow the liks to find out everything about Dicerna Pharmaceuticals Inc Hours.
https://www.nasdaq.com/market-activity/stocks/drna/after-hours
Dicerna Pharmaceuticals, Inc. Common Stock (DRNA) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.
https://www.barrons.com/market-data/stocks/drna/research-ratings
1 day ago · Dicerna Pharmaceuticals Inc. research and ratings by Barron's. View DRNA revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. ... After Hours …
https://www.barrons.com/market-data/stocks/drna
Sep 17, 2021 · Complete Dicerna Pharmaceuticals Inc. stock information by Barron's. View real-time DRNA stock price and news, along with industry-best analysis. ... After Hours Vol. 149.44K. Price at …
https://www.marketwatch.com/investing/stock/DRNA/company-profile
Aug 31, 2021 · Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that …Cash Ratio: 3.20
https://www.nasdaq.com/articles/dicerna-pharmaceuticals-inc.-nasdaq%3Adrna-analysts-are-more-bearish-than-they-used-to-be
Aug 15, 2021 · The analysts covering Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) delivered a dose of negativity to shareholders today, by making a substantial revision to …
https://newsheater.com/2021/08/10/heres-our-rant-about-dicerna-pharmaceuticals-inc-drna/
Aug 10, 2021 · Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA) went down by -12.55% from its latest closing price compared to the recent 1-year high of $40.14. The company’s stock price has collected -35.49% of loss in the last five trading sessions. Press Release reported 17 hours ago that Dicerna Announces Second Quarter 2021 Financial Results and Provides a Business Update
https://newsheater.com/2021/08/06/is-dicerna-pharmaceuticals-inc-drna-a-keeper/
Aug 06, 2021 · Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA) went down by -35.10% from its latest closing price compared to the recent 1-year high of $40.14. The company’s stock price has collected 2.07% of gains in the last five trading sessions. Press Release reported 18 hours ago that Dicerna Reports Positive Top-Line Results From PHYOX(TM)2 Pivotal Clinical Trial of Nedosiran for the …
https://www.benzinga.com/general/biotech/21/08/22371293/the-daily-biotech-pulse-dicerna-slips-on-data-novavax-tightlipped-on-us-vaccine-approval-adagio-i
Aug 06, 2021 · Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) announced positive top-line results from the PHYOX2 pivotal clinical trial of nedosiran, which is …Author: Shanthi Rexaline
https://www.thestreet.com/investing/dicerna-drops-on-mixed-trial-data-for-genetic-disorder-treatment
Aug 07, 2021 · Shares of Dicerna Pharmaceuticals Inc. ( DRNA) - Get Dicerna Pharmaceuticals, Inc. Report slumped on Friday after the drug developer reported mixed results from a …Author: Tony Owusu
Searching for Dicerna Pharmaceuticals Inc Hours?
You can just click the links above. The info is collected for you.
